UNICORN Study: Osimertinib and Other Emerging Treatments for Uncommon EGFR Mutations
Insights into how the UNICORN study, which assessed osimertinib, is impacting treatment decisions for uncommon EGFR mutations, and other ongoing trials shedding light on effective treatments for this patient population.
Source: onclive.com